<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">354577</id>
  <title nil="true"/>
  <common-name>2-[hydroxy-[(e,2s,3r)-3-hydroxy-2-(tetradecanoylamino)octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium</common-name>
  <description>2-[hydroxy-[(e,2s,3r)-3-hydroxy-2-(tetradecanoylamino)octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium is a chemical compound with the formula C37H76N2O6P+. With an average molecular weight of 676.00 g/mol, 2-[hydroxy-[(e,2s,3r)-3-hydroxy-2-(tetradecanoylamino)octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>11433863</pubchem-id>
  <chemical-formula>C37H76N2O6P+</chemical-formula>
  <weight>676</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T22:14:16Z</created-at>
  <updated-at type="dateTime">2026-08-31T22:14:16Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CCCCCCCCCCCCCC=CC(C(COP(=O)(O)OCC[N+](C)(C)C)NC(=O)CCCCCCCCCCCCC)O</moldb-smiles>
  <moldb-formula>C37H76N2O6P+</moldb-formula>
  <moldb-inchi>InChI=1S/C37H75N2O6P/c1-6-8-10-12-14-16-18-19-21-22-24-26-28-30-36(40)35(34-45-46(42,43)44-33-32-39(3,4)5)38-37(41)31-29-27-25-23-20-17-15-13-11-9-7-2/h28,30,35-36,40H,6-27,29,31-34H2,1-5H3,(H-,38,41,42,43)/p+1/b30-28+/t35-,36+/m0/s1</moldb-inchi>
  <moldb-inchikey>KYICBZWZQPCUMO-PSALXKTOSA-O</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">675.5441002</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>11.3</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM350470</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[hydroxy-[(e,2s,3r)-3-hydroxy-2-(tetradecanoylamino)octadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Lipids and lipid-like molecules</superklass>
  <klass>Sphingolipids</klass>
  <subklass>Phosphosphingolipids</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0304858</sync-id>
  <structure-inchikey>KYICBZWZQPCUMO-UHFFFAOYSA-O</structure-inchikey>
  <structure-fingerprint>400400000040000000008000000006000000000000000000800000001000000000800000020000010000000000000000000040020000000000000000020000000000000000000000100100000000080000200000000003000000000000000000010000200110000000000000002000218000400000000000000008000000000000200000400000000000000000000100800000000000000000000000000010000000020000000000000880000000010000000000880000000000000000000000002000080200000000000080000000000000000000000a0000000000000080000000000000020000000000000000010400000000000000000100000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAuAAAALQAAAIABBgBgAAAAAQMGAGAAAAAC
AgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIGAGAA
AAACAgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIG
AGgAAAADAwEGAGgAAAADAwEGAGAAAAADAQYAYAAAAAMBBgBgAAAAAgIIACAA
AAACDwAgAAAABQgAKAAAAAMCCABgAAAAAQEIACAAAAACBgBgAAAAAgIGAGAA
AAACAgcgIgAAAAEEBgBgAAAAAQMGAGAAAAABAwYAYAAAAAEDBwBoAAAAAwIB
BgAoAAAAAwQIACgAAAADAgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAA
AAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYA
YAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAEDCABgAAAAAQELAAEAAQIA
AgMAAwQABAUABQYABgcABwgACAkACQoACgsACwwADA0ADQ4IAg4PAA8QABAR
ABESABITABMUCAITFQATFgAWFwAXGAAYGQAZGgAZGwAZHAAQHQAdHiAeHygC
HiAAICEAISIAIiMAIyQAJCUAJSYAJicAJygAKCkAKSoAKisAKywADy0AQgAA
AAAXBAAAAAAAAAAW
</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:52:31Z</structure-indexed-at>
</compound>
